お知らせ • Jul 01
Hunlicar Group Limited, Annual General Meeting, Sep 24, 2026 Hunlicar Group Limited, Annual General Meeting, Sep 24, 2026. Recent Insider Transactions • Apr 21
Executive Chairman recently bought HK$258k worth of stock On the 14th of April, Lit Wan Cheung bought around 30k shares on-market at roughly HK$8.60 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Lit Wan's only on-market trade for the last 12 months. お知らせ • Jul 01
Hunlicar Group Limited, Annual General Meeting, Sep 25, 2025 Hunlicar Group Limited, Annual General Meeting, Sep 25, 2025. お知らせ • Mar 31
Hunlicar Group Limited Announces Board Changes Hunlicar Group Limited announced that Mr. Qu Hongqing (``Mr Qu'') has tendered his resignation as an executive Director and an authorised representative of the Company. The Board further announces that with effect from 31 March 2025, Mr. Chan Wing Sum, being an executive Director of the Company, has been appointed as an Authorised Representative to fill the vacancy of Mr. Qu. お知らせ • Jan 28
Hunlicar Group Limited Announces Board Changes The board of directors of Hunlicar Group Limited announced the following changes to the Board and its committees with effect from 1 February 2025: Mr. Mao Shuguang (``Mr Mao'') will resign as an independent non-executive Director and will cease to be a member of the audit committee (the ``Audit Committee'') of the Company; Mr. Lee Ka Leung Daniel (``Mr Lee'') will be appointed as an independent non-executive Director and a member of the Audit Committee; Mr. Qu Hongqing (``Mr Qu''), an executive Director, will cease to be the chairman of the corporate governance committee (the ``Corporate Governance Committee''), a member of each of the nomination committee (the ``Nomination Committee'') and the remuneration committee (the ``Remuneration Committee'') of the Company; Ms Luo Ying (``Ms Luo''), an executive Director, will be appointed as a member of each of the Nomination Committee and the Remuneration Committee; Mr. Cheung Lit Wan Kenneth (``Mr Cheung''), the chairman of the Board, will be appointed as a member of the Corporate Governance Committee; and Mr. Leung Wai Kwan (``Mr Leung''), an independent non-executive Director, will be appointed as the chairman of the Corporate Governance Committee .Mr Mao confirmed that he has no disagreement with the Board and there are no other matters that need to be brought to the attention of the Company's shareholders and The Stock Exchange of Hong Kong Limited (the ``Stock Exchange'') in relation to his resignation. Mr. Lee, aged 66, is a certified public accountant with practising certificate. He is a fellow member of the Hong Kong Institute of Certified Public Accountants and the Association of Chartered Certified Accountants. He served as a partner of BDO Limited, Hong Kong member firm of the international accounting network BDO during the period from 2005 to 2023. He was a member of the Chinese People's Political Consultative Conference Hainan Committee during the period from 2013 to 2022. Since 29 November 2023, he has served as an independent non-executive director of Baijin Life Science Holdings Limited. Mr. Lee has entered into a service contract with the Company for a term of three years, and is subject to retirement by rotation and re-election at the general meetings of the Company in accordance with the articles of association of the Company. The appointment of Mr. Lee as an independent non-executive Director can be terminated by three months' notice in writing served by either party on another. Mr. Lee will receive an emolument of HKD 161,000 per annum, which is determined by the Board with reference to his experience, duties and responsibilities in the Company and the current market rate. Mr. Lee has no relationship with any Directors, senior management, substantial or controlling shareholders of the Company. As at the date of this announcement, Mr. Lee has no interest (within the meaning of Part XV of the Securities Futures Ordinance (Chapter 571 of the Laws of Hong Kong)) in the securities of the Company. Save as disclosed above, Mr. Lee has not been a director of any listed companies in the past three years nor held any other position with the Company and/or any of its subsidiaries. Mr. Lee has not been involved in any of the events under Rule 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited and there are no other matters in relation to the aforesaid appointment of Mr. Lee that need to be brought to the attention of the Shareholders. The Board would like to take this opportunity to welcome Mr. Lee to join the Board. お知らせ • Sep 24
Huabang Technology Holdings Limited Announces Board Changes The Board of Huabang Technology Holdings Limited announced that Mr. Li Huaqiang and Mr. Zhu Shouzhong each retired from the office as an independent non-executive Director at the conclusion of the AGM, and accordingly, Mr. Li ceased to be a member of the audit committee, nomination committee, remuneration committee and corporate governance committee of the Company, and Mr. Zhu ceased to be a member of the audit committee of the Company.
Following the retirements of Mr. Li and Mr. Zhu, the Board announced that Mr. Mao Shuguang and Mr. Leung Wai Kwan have each been elected by the Shareholders as an independent non-executive Director. Further, Mr. Mao has been appointed as a member of the audit committee of the Company and Mr. Leung has been appointed as a member of the audit committee, remuneration committee, nomination committee and corporate governance committee of the Company. Following the retirements of Mr. Li and Mr. Zhu, Mr. Mao has been appointed as a member of the audit committee of the Company with effect from 24 September 2024, and Mr. Leung has been appointed as a member of the audit committee, remuneration committee, nomination committee and corporate governance committee of the Company with effect from 24 September 2024.